REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 212 filers reported holding REATA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,700,000 | -25.9% | 11,779 | +4.9% | 0.53% | +4.6% |
| Q4 2019 | $2,295,000 | +212.2% | 11,228 | +22.7% | 0.50% | +160.3% |
| Q3 2019 | $735,000 | -73.1% | 9,150 | -68.4% | 0.19% | -71.0% |
| Q2 2019 | $2,730,000 | -15.8% | 28,933 | -23.7% | 0.67% | -16.0% |
| Q1 2019 | $3,241,000 | +54.5% | 37,917 | +1.4% | 0.80% | +39.5% |
| Q4 2018 | $2,098,000 | -59.4% | 37,406 | -40.8% | 0.57% | -25.8% |
| Q3 2018 | $5,165,000 | – | 63,177 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |